|
Records 1-5 (of 5 Records) |
| Query Trace: Pancreatic cancer[original query] |
|---|
| B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodies. Fox-Fisher Ilana, et al. Med (New York, N.Y.) 2022 0 0. 
|
| TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19. Harford Joe B, et al. Viruses 2022 0 0. (4)
|
| New Roles for Vitamin D Superagonists: From COVID to Cancer. Easty David J, et al. Frontiers in endocrinology 2021 0 0. 644298 |
| COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease. Katopodis Periklis, et al. International journal of molecular medicine 2021 4 0. (4)
|
| Artificial Neural Network Modeling of Novel Coronavirus (COVID-19) Incidence Rates across the Continental United States. Mollalo Abolfazl, et al. International journal of environmental research and public health 2020 6 0. (12) 
|
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:May 31, 2023
- Content source: